MedTrace Logo

Effect of Dexmedetomidine on Gastric Emptying, Assessed by Ultrasound in Laparoscopic Cholecystectomy

NCT06634524 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-09-19

No results posted yet for this study

Summary

The aim of this study is to evaluate the effect of dexmedetomidine on gastric emptying assessed by gastric ultrasound in patients undergoing laparoscopic cholecystectomy.

Conditions

  • Dexmedetomidine
  • Gastric Emptying
  • Ultrasound
  • Laparoscopic Cholecystectomy

Interventions

DRUG

Dexmeditomidine

Patients who will receive IV infusion of (0.2 µg/kg/hr dexmeditomidine).

DRUG

Normal saline

Patients who will receive IV infusion of normal saline, at the same rate of dexmedetomidine infusion.

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-12
Primary Completion
2025-03-01
Completion
2025-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06634524 on ClinicalTrials.gov